Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
about
TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation.Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis.Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation.Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.[Cytokine neutralization at specific cellular source : A new therapeutic paradigm? German Version].Cytokine neutralization at specific cellular source : A new therapeutic paradigm?Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular InteractionsIncreased Potency of a Bi-specific TL1A-ADAM17 (TACE) Inhibitor by Cell Surface Targeting.VHH-Based Bispecific Antibodies Targeting Cytokine ProductionSingle-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.A New Venue of TNF Targeting.Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
P2860
Q36809157-5B809107-EEF0-42BC-A158-67C889E21946Q38758623-1CB08891-6282-4274-8D88-348F9283F4D4Q38885379-458DD9CA-CD6E-479B-9295-92328CBF042BQ39084627-8D1D2EC0-9598-4062-ACF5-462400605467Q40383261-3EE8B285-B7B6-4C85-B659-274620DC0329Q40481990-68C652CA-8ADE-438C-B49A-782110691A12Q41170077-40A028F0-834B-4ACF-B7E9-0A3230BC5E91Q41525669-BD7D9745-40E3-4CE5-95BA-485986F8E1CFQ41619629-465B6FC5-C28B-49A6-BC60-40A8F0EF5E16Q52362264-7DAC44B0-9446-4627-BD1A-736721463434Q55001725-E1CBEAE9-3389-4EC3-ABC8-CEE36372B892Q58724935-BB62255C-D6D9-49A7-B828-17889B8C3000
P2860
Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
@ast
Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
@en
type
label
Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
@ast
Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
@en
prefLabel
Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
@ast
Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
@en
P2093
P2860
P50
P356
P1476
Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
@en
P2093
Andrei A Kruglov
Fedor N Rozov
Grigory A Efimov
Jürgen Scheller
Marina S Drutskaya
Martin Stacey
Sergei A Nedospasov
Sergei V Tillib
Zoya V Khlopchatnikova
P2860
P304
P356
10.1073/PNAS.1520175113
P407
P577
2016-03-02T00:00:00Z